Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.

McLaren PJ, Ripke S, Pelak K, Weintrob AC, Patsopoulos NA, Jia X, Erlich RL, Lennon NJ, Kadie CM, Heckerman D, Gupta N, Haas DW, Deeks SG, Pereyra F, Walker BD, de Bakker PI; International HIV Controllers Study.

Hum Mol Genet. 2012 Oct 1;21(19):4334-47. doi: 10.1093/hmg/dds226. Epub 2012 Jun 19.

PMID:
22718199
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

EEG spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients--a case control study.

Duffy FH, McAnulty GB, McCreary MC, Cuchural GJ, Komaroff AL.

BMC Neurol. 2011 Jul 1;11:82. doi: 10.1186/1471-2377-11-82.

PMID:
21722376
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.

International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD, Ripke S, Brumme CJ, Pulit SL, Carrington M, Kadie CM, Carlson JM, Heckerman D, Graham RR, Plenge RM, Deeks SG, Gianniny L, Crawford G, Sullivan J, Gonzalez E, Davies L, Camargo A, Moore JM, Beattie N, Gupta S, Crenshaw A, Burtt NP, Guiducci C, Gupta N, Gao X, Qi Y, Yuki Y, Piechocka-Trocha A, Cutrell E, Rosenberg R, Moss KL, Lemay P, O'Leary J, Schaefer T, Verma P, Toth I, Block B, Baker B, Rothchild A, Lian J, Proudfoot J, Alvino DM, Vine S, Addo MM, Allen TM, Altfeld M, Henn MR, Le Gall S, Streeck H, Haas DW, Kuritzkes DR, Robbins GK, Shafer RW, Gulick RM, Shikuma CM, Haubrich R, Riddler S, Sax PE, Daar ES, Ribaudo HJ, Agan B, Agarwal S, Ahern RL, Allen BL, Altidor S, Altschuler EL, Ambardar S, Anastos K, Anderson B, Anderson V, Andrady U, Antoniskis D, Bangsberg D, Barbaro D, Barrie W, Bartczak J, Barton S, Basden P, Basgoz N, Bazner S, Bellos NC, Benson AM, Berger J, Bernard NF, Bernard AM, Birch C, Bodner SJ, Bolan RK, Boudreaux ET, Bradley M, Braun JF, Brndjar JE, Brown SJ, Brown K, Brown ST, Burack J, Bush LM, Cafaro V, Campbell O, Campbell J, Carlson RH, Carmichael JK, Casey KK, Cavacuiti C, Celestin G, Chambers ST, Chez N, Chirch LM, Cimoch PJ, Cohen D, Cohn LE, Conway B, Cooper DA, Cornelson B, Cox DT, Cristofano MV, Cuchural G Jr, Czartoski JL, Dahman JM, Daly JS, Davis BT, Davis K, Davod SM, DeJesus E, Dietz CA, Dunham E, Dunn ME, Ellerin TB, Eron JJ, Fangman JJ, Farel CE, Ferlazzo H, Fidler S, Fleenor-Ford A, Frankel R, Freedberg KA, French NK, Fuchs JD, Fuller JD, Gaberman J, Gallant JE, Gandhi RT, Garcia E, Garmon D, Gathe JC Jr, Gaultier CR, Gebre W, Gilman FD, Gilson I, Goepfert PA, Gottlieb MS, Goulston C, Groger RK, Gurley TD, Haber S, Hardwicke R, Hardy WD, Harrigan PR, Hawkins TN, Heath S, Hecht FM, Henry WK, Hladek M, Hoffman RP, Horton JM, Hsu RK, Huhn GD, Hunt P, Hupert MJ, Illeman ML, Jaeger H, Jellinger RM, John M, Johnson JA, Johnson KL, Johnson H, Johnson K, Joly J, Jordan WC, Kauffman CA, Khanlou H, Killian RK, Kim AY, Kim DD, Kinder CA, Kirchner JT, Kogelman L, Kojic EM, Korthuis PT, Kurisu W, Kwon DS, LaMar M, Lampiris H, Lanzafame M, Lederman MM, Lee DM, Lee JM, Lee MJ, Lee ET, Lemoine J, Levy JA, Llibre JM, Liguori MA, Little SJ, Liu AY, Lopez AJ, Loutfy MR, Loy D, Mohammed DY, Man A, Mansour MK, Marconi VC, Markowitz M, Marques R, Martin JN, Martin HL Jr, Mayer KH, McElrath MJ, McGhee TA, McGovern BH, McGowan K, McIntyre D, Mcleod GX, Menezes P, Mesa G, Metroka CE, Meyer-Olson D, Miller AO, Montgomery K, Mounzer KC, Nagami EH, Nagin I, Nahass RG, Nelson MO, Nielsen C, Norene DL, O'Connor DH, Ojikutu BO, Okulicz J, Oladehin OO, Oldfield EC 3rd, Olender SA, Ostrowski M, Owen WF Jr, Pae E, Parsonnet J, Pavlatos AM, Perlmutter AM, Pierce MN, Pincus JM, Pisani L, Price LJ, Proia L, Prokesch RC, Pujet HC, Ramgopal M, Rathod A, Rausch M, Ravishankar J, Rhame FS, Richards CS, Richman DD, Rodes B, Rodriguez M, Rose RC 3rd, Rosenberg ES, Rosenthal D, Ross PE, Rubin DS, Rumbaugh E, Saenz L, Salvaggio MR, Sanchez WC, Sanjana VM, Santiago S, Schmidt W, Schuitemaker H, Sestak PM, Shalit P, Shay W, Shirvani VN, Silebi VI, Sizemore JM Jr, Skolnik PR, Sokol-Anderson M, Sosman JM, Stabile P, Stapleton JT, Starrett S, Stein F, Stellbrink HJ, Sterman FL, Stone VE, Stone DR, Tambussi G, Taplitz RA, Tedaldi EM, Telenti A, Theisen W, Torres R, Tosiello L, Tremblay C, Tribble MA, Trinh PD, Tsao A, Ueda P, Vaccaro A, Valadas E, Vanig TJ, Vecino I, Vega VM, Veikley W, Wade BH, Walworth C, Wanidworanun C, Ward DJ, Warner DA, Weber RD, Webster D, Weis S, Wheeler DA, White DJ, Wilkins E, Winston A, Wlodaver CG, van't Wout A, Wright DP, Yang OO, Yurdin DL, Zabukovic BW, Zachary KC, Zeeman B, Zhao M.

Science. 2010 Dec 10;330(6010):1551-7. doi: 10.1126/science.1195271. Epub 2010 Nov 4.

PMID:
21051598
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.

Ferreira MA, Mangino M, Brumme CJ, Zhao ZZ, Medland SE, Wright MJ, Nyholt DR, Gordon S, Campbell M, McEvoy BP, Henders A, Evans DM, Lanchbury JS, Pereyra F; International HIV Controllers Study, Walker BD, Haas DW, Soranzo N, Spector TD, de Bakker PI, Frazer IH, Montgomery GW, Martin NG.

Am J Hum Genet. 2010 Jan;86(1):88-92. doi: 10.1016/j.ajhg.2009.12.008. Epub 2009 Dec 31.

PMID:
20045101
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.

Snydman DR, Jacobus NV, McDermott LA, Supran S, Cuchural GJ Jr, Finegold S, Harrell L, Hecht DW, Iannini P, Jenkins S, Pierson C, Rihs J, Gorbach SL.

Antimicrob Agents Chemother. 1999 Oct;43(10):2417-22.

PMID:
10508018
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.

Snydman DR, McDermott L, Cuchural GJ Jr, Hecht DW, Iannini PB, Harrell LJ, Jenkins SG, O'Keefe JP, Pierson CL, Rihs JD, Yu VL, Finegold SM, Gorbach SL.

Clin Infect Dis. 1996 Dec;23 Suppl 1:S54-65.

PMID:
8953108
[PubMed - indexed for MEDLINE]
Free Article
7.

Correlation of various in vitro testing methods with clinical outcomes in patients with Bacteroides fragilis group infections treated with cefoxitin: a retrospective analysis.

Snydman DR, Cuchural GJ Jr, McDermott L, Gill M.

Antimicrob Agents Chemother. 1992 Mar;36(3):540-4.

PMID:
1622162
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1989.

Cuchural GJ Jr, Snydman DR, McDermott L, Iannini PB, Hill GB, Cleary TJ, O'Keefe JP, Pierson CL, Rihs JD, Finegold SM.

Clin Ther. 1992 Jan-Feb;14(1):122-36.

PMID:
1576621
[PubMed - indexed for MEDLINE]
9.

Newer beta-lactam agents and the Bacteroides fragilis group.

Cuchural GJ Jr.

Pharmacotherapy. 1991;11(2 ( Pt 2)):51S-55S. Review.

PMID:
2041832
[PubMed - indexed for MEDLINE]
10.

The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.

Cornick NA, Cuchural GJ Jr, Snydman DR, Jacobus NV, Iannini P, Hill G, Cleary T, O'Keefe JP, Pierson C, Finegold SM.

J Antimicrob Chemother. 1990 Jun;25(6):1011-9.

PMID:
2370237
[PubMed - indexed for MEDLINE]
11.

Comparative activities of newer beta-lactam agents against members of the Bacteroides fragilis group.

Cuchural GJ Jr, Tally FP, Jacobus NV, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C.

Antimicrob Agents Chemother. 1990 Mar;34(3):479-80.

PMID:
2334161
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Imipenem resistance in Bacteroides distasonis mediated by a novel beta-lactamase.

Hurlbut S, Cuchural GJ, Tally FP.

Antimicrob Agents Chemother. 1990 Jan;34(1):117-20.

PMID:
2327745
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms.

Jacobus NV, Cuchural GJ Jr, Tally FP.

J Antimicrob Chemother. 1989 Nov;24(5):675-82.

PMID:
2599992
[PubMed - indexed for MEDLINE]
14.

Permeability to beta-lactams in Bacteroides fragilis.

Cuchural GJ, Hurlbut S, Malamy MH, Tally FP.

J Antimicrob Chemother. 1988 Dec;22(6):785-90.

PMID:
3266619
[PubMed - indexed for MEDLINE]
15.

Antibiotic resistance in anaerobic bacteria.

Tally FP, Cuchural GJ Jr.

J Antimicrob Chemother. 1988 Jul;22 Suppl A:63-71.

PMID:
3264832
[PubMed - indexed for MEDLINE]
16.

Susceptibility of the Bacteroides fragilis group in the United States: analysis by site of isolation.

Cuchural GJ Jr, Tally FP, Jacobus NV, Aldridge K, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C, et al.

Antimicrob Agents Chemother. 1988 May;32(5):717-22.

PMID:
3395102
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Antimicrobial resistance in oral and colonic bacteroides.

Crook DW, Cuchural GJ Jr, Jacobus NV, Tally FP.

Scand J Infect Dis Suppl. 1988;57:55-64. Review.

PMID:
3074473
[PubMed - indexed for MEDLINE]
18.

Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.

Bieluch VM, Cuchural GJ, Snydman DR, Gorbach SL, Tally FP.

Diagn Microbiol Infect Dis. 1987 Jun;7(2):119-26.

PMID:
3652652
[PubMed - indexed for MEDLINE]
19.

Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis.

Cuchural GJ Jr, Malamy MH, Tally FP.

Antimicrob Agents Chemother. 1986 Nov;30(5):645-8.

PMID:
3492173
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Bacteroides fragilis: current susceptibilities, mechanisms of drug resistance, and principles of antimicrobial therapy.

Cuchural GJ Jr, Tally FP.

Drug Intell Clin Pharm. 1986 Jul-Aug;20(7-8):567-73.

PMID:
3488895
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk